Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription

被引:260
|
作者
Chiang, JYL
Kimmel, R
Weinberger, C
Stroup, D
机构
[1] NE Ohio Univ, Coll Med, Dept Biochem & Mol Pathol, Rootstown, OH 44272 USA
[2] NIEHS, NIH, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1074/jbc.275.15.10918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholesterol 7 alpha-hydroxylase gene (CYP7A1) transcription is repressed by bile acids. The goal of this study is to elucidate the mechanism of CYP7A1 transcription by bile acid-activated farnesoid X receptor (FXR) in its native promoter and cellular context and to identify FXR response elements in the gene. In Chinese hamster ovary cells transfected with retinoid X receptor alpha (RXR alpha)/FXR, only chenodeoxycholic acid (CDCA) and deoxycholic acid (DCA) were able to stimulate a heterologous promoter/reporter containing an ecdysone response element. In HepG2 cells, all bile acids (25 mu M) were able to repress CYP7A1/luciferase reporter activity, and only CDCA and DCA further repressed reporter activity when cotransfected with RXR alpha/FXR, The concentration of CDCA required to inhibit 50% of reporter activity (IC(50)) was determined to be approximately 25 mu M without FXR and 10 mu M with FXR. Deletion analysis revealed that the bile acid response element located between nucleotides -148 and -128 was the FXR response element, but RXR alpha/FXR did not bind to this sequence. These results suggest that bile acid-activated FXR exerts its inhibitory effect on CYP7A1 transcription by an indirect mechanism, in contrast to the stimulation and binding of FXR to intestinal bile acid-binding protein gene promoter. Results also reveal that bile acid receptors other than FXR are present in HepG2 cells.
引用
收藏
页码:10918 / 10924
页数:7
相关论文
共 50 条
  • [21] Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
    Pullingr, CR
    Eng, C
    Salen, G
    Shefer, S
    Batta, AK
    Erickson, SK
    Verhagen, A
    Rivera, CR
    Mulvihill, SJ
    Malloy, MJ
    Kane, JP
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (01): : 109 - 117
  • [22] Mechanisms for Increased Expression of Cholesterol 7α-Hydroxylase (Cyp7a1) in Lactating Rats
    Wooton-Kee, Clavia Ruth
    Coy, Donna J.
    Athippozhy, Antony T.
    Zhao, Tianyong
    Jones, Brett R.
    Vore, Mary
    HEPATOLOGY, 2010, 51 (01) : 277 - 285
  • [23] -203A/C POLYMORPHISM OF CHOLESTEROL 7α-HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINE
    Kovar, J.
    Zimolova, M.
    Lenicek, M.
    Vitek, L.
    Jirsa, M.
    Poledne, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [24] Cholesterol 7 alpha-hydroxylase (CYP7A1) gene mutation: another cause for gallstone formation?
    Pullinger, CR
    Eng, C
    Malloy, MJ
    Kane, JP
    GALLSTONES: PATHOGENESIS AND TREATMENT, 2004, 139 : 14 - 23
  • [25] Peroxisome proliferators down-regulate the expression of the human cholesterol 7α-hydroxylase gene (CYP7A1).
    Marrapodi, M
    Chiang, JYL
    FASEB JOURNAL, 1999, 13 (07): : A1465 - A1465
  • [26] Bile acids repress cholesterol 7α-hydroxylase gene transcription by recruiting histone deacetylases
    Godio, C
    Mitro, N
    Scotti, E
    De Fabiani, E
    Caruso, D
    Crestani, M
    FASEB JOURNAL, 2006, 20 (04): : A524 - A524
  • [27] -203A/C POLYMORPHISM OF CHOLESTEROL 7α- HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINE
    Kovar, J.
    Zimolova, M.
    Lenicek, M.
    Vitek, L.
    Jirsa, M.
    Poledne, R.
    Pitha, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 199 - 200
  • [28] GPR30, a Novel Estrogen Receptor, Enhances Cholesterol Cholelithogenesis by Inhibiting Cholesterol 7α-Hydroxylase (CYP7A1) and the Classic Pathway of Bile Acid Synthesis
    de Bari, Ornella
    Wang, Helen H.
    Paik, Changnyol
    Garruti, Gabriella
    Liu, Min
    Portincasa, Piero
    Wang, David Q.
    GASTROENTEROLOGY, 2013, 144 (05) : S254 - S254
  • [29] Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis
    Pandak, WM
    Schwarz, C
    Hylemon, PB
    Mallonee, D
    Valerie, K
    Heuman, DM
    Fisher, RA
    Redford, K
    Vlahcevic, ZR
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (04): : G878 - G889
  • [30] Glucagon and cAMP inhibit cholesterol 7α-hydroxylase (CYP7A1) gene expression in human hepatocytes:: Discordant regulation of bile acid synthesis and gluconeogenesis
    Song, KH
    Chiang, JYL
    HEPATOLOGY, 2006, 43 (01) : 117 - 125